Publication | Closed Access

Metabolomic and proteomic analysis of breast cancer patient samples suggests that glutamate and 12-HETE in combination with CA15-3 may be useful biomarkers reflecting tumour burden

BiochemistryMedicineNatural SciencesBiomarker TargetPharmacologyMetabolomic ProfilingBreast CancerUseful BiomarkersMetabolomicsMetabolic ProfilingProteomicsCancer ResearchProteomic AnalysisTumour Burden